Vivid Biotek Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.12 M
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.70 M
- Satisfied Charges ₹ 6.70 M
- Revenue Growth 2.46%
- Profit Growth 47.35%
- Ebitda 69.77%
- Net Worth 5.85%
- Total Assets 8.41%
About Vivid Biotek
Vivid Biotek Private Limited (VBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2004 and has a history of 20 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹0.70 M. The company has closed loans amounting to ₹6.70 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Hanif, Mohammad Wasi, and Suman serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2004PTC128891
- Company No.
128891
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Vivid Biotek Private Limited offer?
Vivid Biotek Private Limited offers a wide range of products and services, including Health Conditions, Fever.
Who are the key members and board of directors at Vivid Biotek?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohd Hanif  | Director | 09-Sep-2004 | Current |
| Mohammad Wasi | Director | 27-Sep-2013 | Current |
| Suman | Director | 27-Sep-2013 | Current |
Financial Performance of Vivid Biotek.
Vivid Biotek Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.46% increase. The company also saw a substantial improvement in profitability, with a 47.35% increase in profit. The company's net worth moved up by a moderate rise of 5.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivid Biotek?
Unlock access to Vivid Biotek's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.70 M
₹6.70 M
Charges Breakdown by Lending Institutions
- Others : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2019 | Others | ₹0.70 M | Open |
| 21 Mar 2006 | The Nanital Bank Ltd | ₹0.30 M | Satisfied |
| 08 Mar 2005 | The Nainital Bank Limited | ₹6.40 M | Satisfied |
How Many Employees Work at Vivid Biotek?
Unlock and access historical data on people associated with Vivid Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivid Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivid Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
